Brief Summary of the Main Points

The Ministry has registered the Russian-made drug Marituperdin for treating anxiety disorders. Its uniqueness lies in its multi-target mechanism, providing both anxiolytic and antidepressant effects, according to ...

The Ministry of Health has excluded the registration certificate for the pharmaceutical substance levocarnitine (trade name: Levocarnitine) produced by Russian company Evalar from the GRLS. This drug is used globally for serious kidney diseases requiring dialysis. ...

The Ministry’s Department for Drug and Medical Device Regulation issued a notice to manufacturers of cefpodoxime-based antibiotics (included in the Essential Drugs List). The notice requires updates to the Summary of Product Characteristics and ...

Another successful master class of the Russian Society of Colorectal Surgeons was held in St. Petersburg – an event that brings together leading coloproctology experts from Russia and abroad. “GemaTech,” an active ...

The Russian Ministry of Health has submitted a revised draft of the order “On Approval of the Procedure for the Use of Clinical Guidelines (CG)” for approval by professional associations. Published on ...

The Russian Ministry of Health has canceled registration certificates for six drugs, based on requests from the authorized legal entities. Three of the drugs are produced by JSC Khimfarm: Akrimex (ethylmethylhydroxypyridine succinate), ...

The Ministry of Health of the Russian Federation has approved the use of divozilumab, developed by Biocad, for a new indication – systemic scleroderma.

The Ministry of Health has authorized Nextgen (Artgen Biotech) to conduct a Phase III clinical trial of the gene therapy drug Neovasculgen for the treatment of diabetic foot syndrome. The study will involve 188 patients across ...

The Ministry of Health has canceled the state registration of 43 drugs and one pharmaceutical substance. The majority of these (31 products) are manufactured by Sandoz. Additionally, the use of two drugs was suspended, according to ...

The Ministry of Health of the Russian Federation proposes to increase from February 1 to 1,326.4 rubles the standard of financial costs per month per Russian receiving state social assistance in the form of provision of medicines, medical devices, as well as ...